Have Malaria Infections in Kenya Become Less Responsive to Artemisinin Treatment?
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether P. falciparum infections in Kilifi District
have developed tolerance to the artemisinin class of drugs.
Phase:
Phase 4
Details
Lead Sponsor:
KEMRI-Wellcome Trust Collaborative Research Program